MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/bmj.e5660

Медицинская библиотека · BMJ (Clinical research ed.) · 2012

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).

Pijpe Anouk, Andrieu Nadine, Easton Douglas F, Kesminiene Ausrele, Cardis Elisabeth, Noguès Catherine, Gauthier-Villars Marion, Lasset Christine, Fricker Jean-Pierre, Peock Susan, Frost Debra, Evans D Gareth, Eeles Rosalind A, Paterson Joan, Manders Peggy, van Asperen Christi J, Ausems Margreet G E M, Meijers-Heijboer Hanne, Thierry-Chef Isabelle, Hauptmann Michael, Goldgar David, Rookus Matti A, van Leeuwen Flora E, GENEPSO, EMBRACE, HEBON

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

To estimate the risk of breast cancer associated with diagnostic radiation in carriers of BRCA1/2 mutations.

DESIGN

Retrospective cohort study (GENE-RAD-RISK).

SETTING

Three nationwide studies (GENEPSO, EMBRACE, HEBON) in France, United Kingdom, and the Netherlands,

PARTICIPANTS

1993 female carriers of BRCA1/2 mutations recruited in 2006-09.

MAIN OUTCOME MEASURE: Risk of breast cancer estimated with a weighted Cox proportional hazards model with a time dependent individually estimated cumulative breast dose, based on nominal estimates of organ dose and frequency of self reported diagnostic procedures. To correct for potential survival bias, the analysis excluded carriers who were diagnosed more than five years before completion of the study questionnaire.

RESULTS

In carriers of BRCA1/2 mutations any exposure to diagnostic radiation before the age of 30 was associated with an increased risk of breast cancer (hazard ratio 1.90, 95% confidence interval 1.20 to 3.00), with a dose-response pattern. The risks by quarter of estimated cumulative dose <0.0020 Gy, ≥ 0.0020-0.0065 Gy, ≥ 0.0066-0.0173 Gy, and ≥ 0.0174 Gy were 1.63 (0.96 to 2.77), 1.78 (0.88 to 3.58), 1.75 (0.72 to 4.25), and 3.84 (1.67 to 8.79), respectively. Analyses on the different types of diagnostic procedures showed a pattern of increasing risk with increasing number of radiographs before age 20 and before age 30 compared with no exposure. A history of mammography before age 30 was also associated with an increased risk of breast cancer (hazard ratio 1.43, 0.85 to 2.40). Sensitivity analysis showed that this finding was not caused by confounding by indication of family history.

CONCLUSION

In this large European study among carriers of BRCA1/2 mutations, exposure to diagnostic radiation before age 30 was associated with an increased risk of breast cancer at dose levels considerably lower than those at which increases have been found in other cohorts exposed to radiation. The results of this study support the use of non-ionising radiation imaging techniques (such as magnetic resonance imaging) as the main tool for surveillance in young women with BRCA1/2 mutations.

Для цитирования: Pijpe Anouk, Andrieu Nadine, Easton Douglas F, Kesminiene Ausrele, Cardis Elisabeth, Noguès Catherine, Gauthier-Villars Marion, Lasset Christine, Fricker Jean-Pierre, Peock Susan, Frost Debra, Evans D Gareth, Eeles Rosalind A, Paterson Joan, Manders Peggy, van Asperen Christi J, Ausems Margreet G E M, Meijers-Heijboer Hanne, Thierry-Chef Isabelle, Hauptmann Michael, Goldgar David, Rookus Matti A, van Leeuwen Flora E, GENEPSO, EMBRACE, HEBON. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).. BMJ (Clinical research ed.). 2012. DOI: 10.1136/bmj.e5660.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.